Back to top

4D Molecular releases phase 2 data for wet AMD asset 4D-150

4D Molecular releases phase 2 data for wet AMD asset 4D-150

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

4D Molecular Therapeutics, Inc. (FDMT)

Regeneron Pharmaceuticals, Inc. (REGN)